Dream suppression
Dream suppression is defined as a decrease in the vividness, intensity, frequency, and recollection of a person's dreams. At its lower levels, this can be a partial suppression which results in the person having dreams of a lesser intensity and a lower rate of frequency. However, at its higher levels, this can be a complete suppression which results in the person not experiencing any dreams at all.
Dream suppression is most commonly induced under the influence of moderate dosages of cannabinoids[1] and most types of antidepressants[2][3][4]. This is due to the way in which they increase REM latency, decrease REM sleep, reduce total sleep time and efficiency, and increase wakefulness.[1][2][3][5] REM sleep is where the majority of dreams occur.[6]
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 5F-AKB48
- 5F-PB-22
- AB-FUBINACA
- APICA
- Alprazolam
- Amphetamine
- Benzodiazepines
- Bromazolam
- Cannabis
- Clonazepam
- Clonazolam
- Diazepam
- Diclazepam
- Etizolam
- Flubromazepam
- Flubromazolam
- Flunitrazepam
- Flunitrazolam
- JWH-018
- JWH-073
- MDEA
- MDMA
- Memantine
- Nifoxipam
- Oxazepam
- PMA
- PMMA
- Phenazepam
- STS-135
- Selective serotonin reuptake inhibitor
- THJ-018
- THJ-2201
Experience reports
Annectdotal reports which describe this effect with our experience index include:
See also
External links
References
- ↑ 1.0 1.1 Schierenbeck, Thomas; Riemann, Dieter; Berger, Mathias; Hornyak, Magdolna (2008). "Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana". Sleep Medicine Reviews. 12 (5): 381–389. doi:10.1016/j.smrv.2007.12.004. ISSN 1087-0792.
- ↑ 2.0 2.1 Sharpley, Ann L.; Cowen, Philip J. (1995). "Effect of pharmacologic treatments on the sleep of depressed patients". Biological Psychiatry. 37 (2): 85–98. doi:10.1016/0006-3223(94)00135-P. ISSN 0006-3223.
- ↑ 3.0 3.1 Trivedi, M (1999). "Effects of Fluoxetine on the Polysomnogram in Outpatients with Major Depression". Neuropsychopharmacology. 20 (5): 447–459. doi:10.1016/S0893-133X(98)00131-6. ISSN 0893-133X.
- ↑ Vogel, G.W.; Buffenstein, A.; Minter, K.; Hennessey, Ann (1990). "Drug effects on REM sleep and on endogenous depression". Neuroscience & Biobehavioral Reviews. 14 (1): 49–63. doi:10.1016/S0149-7634(05)80159-9. ISSN 0149-7634.
- ↑ Feinberg, I., Jones, R., Walker, J. M., Cavness, C., March, J. (April 1975). "Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man". Clinical Pharmacology & Therapeutics. 17 (4): 458–466. doi:10.1002/cpt1975174458. ISSN 0009-9236. Retrieved 4 June 2022.
- ↑ Hobson, J. A., Stickgold, R., Pace-Schott, E. F. (February 1998). "The neuropsychology of REM sleep dreaming:". NeuroReport. 9 (3): R1–R14. doi:10.1097/00001756-199802160-00033. ISSN 0959-4965. Retrieved 4 June 2022.